KLOW Blend (KPV+BPC+TB+CU)
Preclinical — Animal / cell-model data onlyWhat it is
A four-way blend of KPV, BPC-157, TB-500 and a copper peptide, marketed for recovery and skin. Component evidence is largely preclinical.
A four-component blend (KPV, BPC-157, TB-500 and a copper peptide) marketed for recovery and skin. Not studied as a combined product.
Research context
Studied in relation to:
- Recovery & skin research
Points in its favour in the literature:
- Multi-component recovery blend
Caveats and unknowns:
- Unstudied as a combined product
- Components unlicensed for human use
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Published clinical / research context (not instructions)No validated blend dose — follow the individual components and supplier guidance.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)Reconstitute by total peptide, e.g. 80 mg + 3–5 mL bacteriostatic water.
Available research formats
| Strength | SKU |
|---|---|
| 80mg | KLOW80 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.